Botond Timar, Ph.D.
Affiliations: | 2006 | Semmelweis Egyetem, Hungary |
Area:
OncologyGoogle:
"Botond Timar"Parents
Sign in to add mentor| Andras Matolcsy | grad student | 2006 | Semmelweis Egyetem | |
| (A chronicus lymphocytas leukaemia es a diffuz nagy b-sejtes lymphoma immunglobulin nehezlanc genjeinek mutacios statusza richter szindromaban.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nagy Á, Bátai B, Kiss L, et al. (2023) Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma. Journal of Internal Medicine |
| Krizsán S, Péterffy B, Egyed B, et al. (2023) NEXT-GENERATION SEQUENCING-BASED GENOMIC PROFILING OF CHILDREN WITH ACUTE MYELOID LEUKEMIA. The Journal of Molecular Diagnostics : Jmd |
| Nagy ZF, Ferenczi K, Istenes I, et al. (2022) Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia. Pathology Oncology Research : Por. 28: 1610338 |
| Gángó A, Kiss R, Farkas P, et al. (2021) Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology |
| Czeti Á, Szalóki G, Varga G, et al. (2021) Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry. Cytometry. Part a : the Journal of the International Society For Analytical Cytology |
| Csernus B, Timár B, Fülöp Z, et al. (2020) Grade I, II and III Follicular Lymphomas Express Ig V Genes with Different Patterns of Somatic Mutation. Pathology Oncology Research : Por |
| Omidvar N, Tekin N, Conget P, et al. (2020) Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System. Acta Haematologica. 1-3 |
| Saft L, Timar B, Porwit A. (2020) Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification Journal of Hematopathology. 13: 79-88 |
| Mózes R, Gángó A, Sulák A, et al. (2018) Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology |
| Gángó A, Mózes R, Boha Z, et al. (2018) Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Leukemia Research. 65: 42-48 |